Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our August issue of Pharmaceutical Executive
FEATURES

Cover Story
 Pricing's Blustery Headwinds: Pharm Exec's 15th Annual Industry Audit
Bill Trombetta
Our latest industry review of shareholder value reveals a sharp performance differential between companies with specialized therapeutic focus and those relying on line diversity, size and scale.
From the Editor
The Industry Audit: Fifteen Years Right
William Looney
With our annual Industry Audit marking its 15th year, William Looney compares 2002 approaches in boosting shareholder value to those of today. The fall in one particular performance metric is telling.
Roundtable
 Dealmaking in 2016: It's Complicated
Casey McDonald
Pharm Exec convenes some of the industry's top business development professionals and negotiators to talk about the current climate for biophamara dealmaking and the critical job of appraising new assets and their potential as market-worthy and transformative products for patients.
Interview
 Steady Hands: AmerisourceBergen's Peyton Howell
 William Looney
Pharm Exec sits down with AmerisourceBergen supply chain leader Peyton Howell to discuss the latest trends in pharmaceutical distribution, including company efforts to boost efficiency, reliability, and enhance its groundbreaking partnership with Walgreens Boots Alliance.
ALSO IN THIS ISSUE
 The 'Cure'-All for 21st Century Data Sharing
Pamela Neely Buffone
Balancing today's health data demands and patient privacy is not about new regulations–it's taking a risk-based approach.

 Drug Shortages Raise Economic and Ethical Challenges
Jill Wechsler
Analysts examine investment and business factors that shape supply disruptions.

On and Off the Pharma Podium
Casey McDonald
In the spirit of the Olympics, we cite some of the feel-good and not-so-good stories making waves in the competitive world of pharma.
 
WEBCASTS
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
Understanding the Chronic Disease Patient Journey in Emerging Markets
Four Strategies You Need to Maximize the Value of Your Data
 
Download the
issue:
 
image

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn